✨
AI Summary
- Benjamin Oakes discusses Scribe Therapeutics' CRISPR and epigenetic editing tools.
- Focus on moving genetic medicine beyond rare diseases into cardiometabolic indications.
- Highlights engineered CasX platform and preclinical data for specificity.
Guests on This Episode
BO
Benjamin Oakes
1 podcast appearance